HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Intravitreal aflibercept for macular edema secondary to central retinal vein occlusion: 18-month results of the phase 3 GALILEO study.

AuthorsDan Călugăru, Mihai Călugăru
JournalAmerican journal of ophthalmology (Am J Ophthalmol) Vol. 159 Issue 3 Pg. 607-8 (Mar 2015) ISSN: 1879-1891 [Electronic] United States
PMID25681022 (Publication Type: Letter, Comment)
Chemical References
  • Recombinant Fusion Proteins
  • Receptors, Vascular Endothelial Growth Factor
Topics
  • Female
  • Humans
  • Macular Edema (drug therapy)
  • Male
  • Receptors, Vascular Endothelial Growth Factor (administration & dosage)
  • Recombinant Fusion Proteins (administration & dosage)
  • Retinal Vein Occlusion (complications)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: